Grading on Sydney Innovation cross-domain (test)
51.45F1 (Overall)VOLMO-2B
Evaluation results
| Method | Links | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VOLMO-2Bsetting=Cross-Domain Grading2026.03 | 51.45 | 64.01 | 89.93 | 78.06 | 67.85 | 84.56 | 22.43 | 51.23 | 78.39 | 47.32 | 41.79 | 93.61 | 50.99 | 81.1 | 95.5 | 58.47 | 78.1 | 97.59 | |
| MedGemma-4Bsetting=Cross-Domain Grading2026.03 | 44.5 | 49.24 | 91.78 | 92.89 | 94.96 | 75.45 | 23.62 | 19.92 | 96.55 | 43.76 | 32.9 | 96.8 | 18.3 | 27.95 | 94.16 | 43.92 | 70.48 | 95.93 | |
| RETFoundsetting=Cross-Domain Grading2026.03 | 40.18 | 49.02 | 87.21 | 85.65 | 88.22 | 54.08 | 10.02 | 8.16 | 96.14 | 21.25 | 14.15 | 96.52 | 34.28 | 73.62 | 91.59 | 49.71 | 60.95 | 97.72 | |
| MedGemma-27Bsetting=Cross-Domain Grading2026.03 | 39.96 | 46.39 | 90.49 | 92.8 | 98 | 65.89 | 13.91 | 9.11 | 98.46 | 35.47 | 23.69 | 98.19 | 17 | 21.65 | 95.63 | 40.63 | 79.52 | 94.27 | |
| InternVL-2Bsetting=Cross-Domain Grading2026.03 | 1.23 | 20 | 80 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 6.17 | 100 | 0 | 0 | 0 | 100 | |
| LLaVA-Medsetting=Cross-Domain Grading2026.03 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 |